Literature DB >> 7771712

Gender differences in cancer of the larynx.

M S Kokoska1, J F Piccirillo, B H Haughey.   

Abstract

Gender differences in the incidence and mortality rates for cancers of the lung, colon, and larynx have previously been noted. The goal of this project was to identify gender differences in prognostic variables for survival and recurrence for patients with cancer of the larynx. The medical records of 193 patients with cancer of the larynx treated initially between 1973 and 1985 were examined retrospectively. A total of 151 men and 42 women were included. A majority of men developed glottic cancers, whereas a majority of women developed supraglottic cancers. Age was prognostically important for both genders; however, comorbidity, symptom severity, anatomic subsite, and TNM stage all had different impacts on survival and recurrence in men and women. No gender difference in initial treatment was found. This study suggests that when designing and analyzing the results from clinical studies of cancer of the larynx, it is important to employ stratification based on gender.

Entities:  

Mesh:

Year:  1995        PMID: 7771712     DOI: 10.1177/000348949510400601

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  No evidence of sex-related survival disparities among head and neck cancer patients receiving similar multidisciplinary care: a matched-pair analysis.

Authors:  Jess C Roberts; Guojun Li; Lorraine R Reitzel; Qingyi Wei; Erich M Sturgis
Journal:  Clin Cancer Res       Date:  2010-10-13       Impact factor: 12.531

2.  Primary carcinoma of the larynx in females: A case series.

Authors:  Y Oukessou; A Chebaatha; O Berrada; R L Abada; S Rouadi; M Roubal; M Mahtar; M Regragui; M Karkouri
Journal:  Ann Med Surg (Lond)       Date:  2022-05-25

3.  Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center.

Authors:  Jesper Brandstorp-Boesen; Ragnhild Sørum Falk; Morten Boysen; Kjell Brøndbo
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-29       Impact factor: 2.503

4.  Human papillomavirus prevalence in invasive laryngeal cancer in the United States.

Authors:  Brenda Y Hernandez; Marc T Goodman; Charles F Lynch; Wendy Cozen; Elizabeth R Unger; Martin Steinau; Trevor Thompson; Maria Sibug Saber; Sean F Altekruse; Christopher Lyu; Mona Saraiya
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.